Catalyst Wire Dossier Catalyst Wire Dossier

Becolomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI (HFA-134a)

budesonide/formoterol · Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Becolomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI (HFA-134a), covering 2020-08-03 to 2020-08-03. Get the full timeline:

Most recent: Clinical Trial Update: EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI [Phase 3]

See pricing